ARCHIVES

FDA Selects 23 Survivors To Review Drug Applications.

This article is from The Cancer Letter archive.

Vol. 27 No. 24 | June 15, 2001

Download PDF Visit The Full Archive

Related Articles

Letter: Medicare Policy May Delay Access to Cancer Drugs

June 13, 2003

Multi-Gene Assay Predicts Recurrence In Newly Diagnosed Breast Cancer

December 26, 2003

Harvard Physician Whose Cancer Was Spread Through Morcellation Seeks to Revamp FDA Regulation of Medical Devices

July 4, 2014

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

March 21, 1997

Northwestern, Rochester, Howard First In Line For Limited Construction Funds

August 20, 1976

NCI Proposes Extension Of Breast Cancer Screening To Determine Efficacy Of Biennial Tests

November 7, 1975